Feasibility of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02505555
Recruitment Status : Unknown
Verified July 2015 by Bai Wen-Pei, Peking University First Hospital. Recruitment status was: Recruiting
The purpose of this study is to summarize our experience with and to evaluate the feasibility of transvaginal four-dimensional hysterosalpingo-contrast sonography using SonoVue (4D-HyCoSy) for assessment of fallopian tubal patency, women attending the fertility clinic are recruited. All of the patients are tried to be examined with 4D-HyCoSy,some of who undergone laparoscopy and dye. Then the results of 4D-HyCoSy and lap and dye are compared. All of the patients will be followed up. The complications of 4D-HyCoSy will be evaluated and the pregnancy outcomes will be recorded.
Condition or disease
Four Dimensional Hysterosalpingo-contrast SonographyTubal Patency
Device: four dimensional hysterosalpingo-contrast sonography
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Women who have infertility and try to evaluate tubal patency by 4D-HyCoSy in our hospital will be recruited.
Women who have infertility and need to evaluate tubal patency.
acute or subacute inflammation of the reproductive system;
allergies to the medications used in the examination, such as lidocaine, atropine, and sulfur hexafluoride